BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 33941139)

  • 1. A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma.
    Zhao C; Zhou Y; Ma H; Wang J; Guo H; Liu H
    BMC Oral Health; 2021 May; 21(1):232. PubMed ID: 33941139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
    Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
    BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
    Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
    Front Immunol; 2022; 13():922195. PubMed ID: 35935989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prognostic Model Based on Cisplatin-Resistance Related Genes in Oral Squamous Cell Carcinoma.
    Lu R; Yang Q; Liu S; Sun L
    Oral Health Prev Dent; 2024 Jan; 22():39-50. PubMed ID: 38223960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MicroRNA model that can predict the prognosis of oral squamous cell carcinoma based on bioinformatics analysis].
    Zhao G; Li CX; Guo C; Zhu H
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Dec; 38(6):622-627. PubMed ID: 33377337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and Analysis of Hypoxia-Related Model in Oral Squamous Cell Carcinoma.
    Lu X; Liu X
    J Healthc Eng; 2022; 2022():6602648. PubMed ID: 35432823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatic analysis and experimental validation of cuproptosis-related LncRNA as a novel biomarker for prognosis and immunotherapy of oral squamous cell carcinoma.
    Liang S; Ji L; Yu Z; Cheng Y; Gao R; Yan W; Zhang F
    Hereditas; 2024 Feb; 161(1):10. PubMed ID: 38414024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
    Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D
    BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a lncRNA-based prognostic signature for oral squamous cell carcinoma.
    Xu Z; Li X; Pan L; Tan R; Ji P; Tang H
    J Oral Pathol Med; 2022 Apr; 51(4):358-368. PubMed ID: 35100473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prognostic Risk Score model for oral squamous cell carcinoma constructed by 6 glycolysis-immune-related genes.
    Liu Y; Wang T; Li R
    BMC Oral Health; 2022 Aug; 22(1):324. PubMed ID: 35922788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel T-cell proliferation-associated gene predicts prognosis and reveals immune infiltration in patients with oral squamous cell carcinoma.
    Cui Y; Cheng Y; Huang W; Liu J; Zhang X; Bu M; Li X
    Arch Oral Biol; 2023 Aug; 152():105719. PubMed ID: 37178584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
    Zhang YY; Mao MH; Han ZX
    Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Nine M6A-Related Long Noncoding RNAs as Prognostic Signatures Associated with Oxidative Stress in Oral Cancer Based on Data from The Cancer Genome Atlas.
    Shan L; Lu Y; Song Y; Zhu X; Xiang CC; Zuo ED; Cheng X
    Oxid Med Cell Longev; 2022; 2022():9529814. PubMed ID: 35910847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of tumor-infiltrating immune cells in clinical early-stage oral squamous cell carcinoma.
    Huang Z; Lu Y; Wang W; Xie N; Yi C; Xiong G; Xu X; Zhang M; Wang C
    J Oral Pathol Med; 2023 May; 52(5):372-380. PubMed ID: 36135715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic model revealing pyroptosis-related signatures in oral squamous cell carcinoma based on bioinformatics analysis.
    Qi L; Tang Z
    Sci Rep; 2024 Mar; 14(1):6149. PubMed ID: 38480853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-CpG-based prognostic signature for oral squamous cell carcinoma overall survival.
    Chen Y; Hei N; Zhao J; Peng S; Yang K; Chen H; Cui Z; Jin L; Sun R; Guo J
    J Cell Biochem; 2019 Jun; 120(6):9082-9090. PubMed ID: 30548666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitination, SUMOylation, and NEDDylation related genes serve as prognostic and therapeutic biomarkers for oral squamous cell carcinoma.
    Deng SZ; Wu X; Kong L; Cheng B; Dai L
    J Oral Pathol Med; 2024 Feb; 53(2):114-123. PubMed ID: 38234119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel and independent survival prognostic model for OSCC: the functions and prognostic values of RNA-binding proteins.
    Wang S; Liu S; Zhu Y; Zhang B; Yang Y; Li L; Sun Y; Zhang L; Fan L; Hu X; Huang C
    Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):397-409. PubMed ID: 37656222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Validation of a Prognostic Signature Derived from the Cancer Stem Cells for Oral Squamous Cell Carcinoma.
    Shi M; Huang K; Wei J; Wang S; Yang W; Wang H; Li Y
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.